A Multifactorial Role for P. falciparum Malaria in Endemic Burkitt's Lymphoma Pathogenesis

PLoS Pathogens

Volumn 10, Issue 5, 2014, Pages

  Torgbor, Charles ^a,b   Awuah, Peter ^c   Deitsch, Kirk ^d   Kalantari, Parisa ^e   Duca, Karen A ^b   Thorley Lawson, David A ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b KUMASI CENTRE FOR COLLABORATIVE RESEARCH IN TROPICAL MEDICINE   (Ghana)

^c KOMFO ANOKYE TEACHING HOSPITAL   (Ghana)

^d WEILL CORNELL MEDICAL COLLEGE   (United States)

^e UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOZOIN; TOLL LIKE RECEPTOR 9;

ARTICLE; BURKITT LYMPHOMA; CANCER INCIDENCE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; MALARIA FALCIPARUM; MALE; MICROSCOPY; MULTIFACTORIAL INHERITANCE; NONHUMAN; ONCOGENE C MYC; PATHOGENESIS; POLYMERASE CHAIN REACTION; STIMULATION; WESTERN BLOTTING; ANIMAL; CELL LINE; EPSTEIN BARR VIRUS; EPSTEIN BARR VIRUS INFECTION; GENE TRANSLOCATION; GENETICS; IMMUNOLOGY; PARASITOLOGY; PHYSIOLOGY; PLASMODIUM FALCIPARUM; VIROLOGY;

ANIMALS; BURKITT LYMPHOMA; CELL LINE; EPSTEIN-BARR VIRUS INFECTIONS; HERPESVIRUS 4, HUMAN; HUMANS; MALARIA, FALCIPARUM; PLASMODIUM FALCIPARUM; TRANSLOCATION, GENETIC;

EID: 84901652376     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1004170     Document Type: Article

References (54)

1. Goldstein JA, Bernstein RL, (1990) Burkitt's lymphoma and the role of Epstein-Barr virus. J Trop Pediatr 36: 114-120.
2. Klein U, Dalla-Favera R, (2008) Germinal centres: role in B-cell physiology and malignancy. Nat Rev Immunol 8: 22-33.
3. Victora GD, Dominguez-Sola D, Holmes AB, Deroubaix S, Dalla-Favera R, et al. (2012) Identification of human germinal center light and dark zone cells and their relationship to human B-cell lymphomas. Blood 120: 2240-2248.
4. Klein G, (1983) Specific chromosomal translocations and the genesis of B-cell-derived tumors in mice and men. Cell 32: 311-315.
5. Leder P (1985) Translocations among antibody genes in human cancer. In: Lenoir GM, O'Conor GT, Olweny CLM, editors. Burkitt's Lymphoma: a human cancer model. New York: Oxford University Press. pp. 341-371.
6. Manolov G, Manolova Y, (1972) Marker band in one chromosome 14 from Burkitt lymphomas. Nature 237: 33-34.
7. Ramiro AR, Jankovic M, Callen E, Difilippantonio S, Chen HT, et al. (2006) Role of genomic instability and p53 in AID-induced c-myc-Igh translocations. Nature 440: 105-109.
8. Ramiro AR, Jankovic M, Eisenreich T, Difilippantonio S, Chen-Kiang S, et al. (2004) AID is required for c-myc/IgH chromosome translocations in vivo. Cell 118: 431-438.
9. Robbiani DF, Bothmer A, Callen E, Reina-San-Martin B, Dorsett Y, et al. (2008) AID is required for the chromosomal breaks in c-myc that lead to c-myc/IgH translocations. Cell 135: 1028-1038.
10. Muramatsu M, Kinoshita K, Fagarasan S, Yamada S, Shinkai Y, et al. (2000) Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme. Cell 102: 553-563.
11. Burkitt D, (1962) A children's cancer dependent on climatic factors. Nature 194: 232-234.
12. Morrow RH, Jr. (1985) Epidemiological evidence for the role of falciparum malaria in the pathogenesis of Burkitt's lymphoma. IARC Sci Publ: 177-186.
13. Kieff E, Rickinson AB (2007) Epstein-Barr Virus and Its Replication. In: Knipe DM, Howley PM, editors. Fields Virology. 5th ed. Philadelphia: Lippincott Williams & Wilkins. pp. 2603-2654.
14. Thorley-Lawson DA, Gross A, (2004) Persistence of the Epstein-Barr virus and the origins of associated lymphomas. N Engl J Med 350: 1328-1337.
15. Babcock GJ, Decker LL, Volk M, Thorley-Lawson DA, (1998) EBV persistence in memory B cells in vivo. Immunity 9: 395-404.
16. Thorley-Lawson DA, (2001) Epstein-Barr virus: exploiting the immune system. Nat Rev Immunol 1: 75-82.
17. Babcock GJ, Hochberg D, Thorley-Lawson AD, (2000) The expression pattern of Epstein-Barr virus latent genes in vivo is dependent upon the differentiation stage of the infected B cell. Immunity 13: 497-506.
18. Roughan JE, Thorley-Lawson DA, (2009) The intersection of Epstein-Barr virus with the germinal center. J Virol 83: 3968-3976.
19. Paschos K, Parker GA, Watanatanasup E, White RE, Allday MJ, (2012) BIM promoter directly targeted by EBNA3C in polycomb-mediated repression by EBV. Nucleic Acids Res 40: 7233-7246.
20. Vereide DT, Seto E, Chiu YF, Hayes M, Tagawa T, et al. (2013) Epstein-Barr virus maintains lymphomas via its miRNAs. Oncogene 33: 1258-1264.
21. Westhoff Smith D, Sugden B, (2013) Potential cellular functions of Epstein-Barr Nuclear Antigen 1 (EBNA1) of Epstein-Barr Virus. Viruses 5: 226-240.
22. Thorley-Lawson DA, Allday MJ, (2008) The curious case of the tumour virus: 50 years of Burkitt's lymphoma. Nat Rev Microbiol 6: 913-924.
23. Hochberg D, Middeldorp JM, Catalina M, Sullivan JL, Luzuriaga K, et al. (2004) Demonstration of the Burkitt's lymphoma Epstein-Barr virus phenotype in dividing latently infected memory cells in vivo. Proc Natl Acad Sci U S A 101: 239-244.
24. Moormann AM, Chelimo K, Sumba PO, Tisch DJ, Rochford R, et al. (2007) Exposure to holoendemic malaria results in suppression of Epstein-Barr virus-specific T cell immunosurveillance in Kenyan children. J Infect Dis 195: 799-808.
25. Moormann AM, Chelimo K, Sumba OP, Lutzke ML, Ploutz-Snyder R, et al. (2005) Exposure to holoendemic malaria results in elevated Epstein-Barr virus loads in children. J Infect Dis 191: 1233-1238.
26. Rasti N, Falk KI, Donati D, Gyan BA, Goka BQ, et al. (2005) Circulating epstein-barr virus in children living in malaria-endemic areas. Scand J Immunol 61: 461-465.
27. Babcock GJ, Decker LL, Freeman RB, Thorley-Lawson DA, (1999) Epstein-barr virus-infected resting memory B cells, not proliferating lymphoblasts, accumulate in the peripheral blood of immunosuppressed patients. J Exp Med 190: 567-576.
28. Hopwood P, Crawford DH, (2000) The role of EBV in post-transplant malignancies: a review. J Clin Pathol 53: 248-254.
29. Xu Z, Pone EJ, Al-Qahtani A, Park SR, Zan H, et al. (2007) Regulation of aicda expression and AID activity: relevance to somatic hypermutation and class switch DNA recombination. Crit Rev Immunol 27: 367-397.
30. Arese P, Schwarzer E, (1997) Malarial pigment (haemozoin): a very active 'inert' substance. Ann Trop Med Parasitol 91: 501-516.
31. Coban C, Ishii KJ, Kawai T, Hemmi H, Sato S, et al. (2005) Toll-like receptor 9 mediates innate immune activation by the malaria pigment hemozoin. J Exp Med 201: 19-25.
32. Parroche P, Lauw FN, Goutagny N, Latz E, Monks BG, et al. (2007) Malaria hemozoin is immunologically inert but radically enhances innate responses by presenting malaria DNA to Toll-like receptor 9. Proc Natl Acad Sci U S A 104: 1919-1924.
33. Smit LA, Bende RJ, Aten J, Guikema JE, Aarts WM, et al. (2003) Expression of activation-induced cytidine deaminase is confined to B-cell non-Hodgkin's lymphomas of germinal-center phenotype. Cancer Res 63: 3894-3898.
34. Cutrona G, Dono M, Pastorino S, Ulivi M, Burgio VL, et al. (1997) The propensity to apoptosis of centrocytes and centroblasts correlates with elevated levels of intracellular myc protein. Eur J Immunol 27: 234-238.
35. Dominguez-Sola D, Victora GD, Ying CY, Phan RT, Saito M, et al. (2012) The proto-oncogene MYC is required for selection in the germinal center and cyclic reentry. Nat Immunol 13: 1083-1091.
36. Klein U, Tu Y, Stolovitzky GA, Keller JL, Haddad J Jr, et al. (2003) Transcriptional analysis of the B cell germinal center reaction. Proc Natl Acad Sci U S A 100: 2639-2644.
37. Martinez-Valdez H, Guret C, de Bouteiller O, Fugier I, Banchereau J, et al. (1996) Human germinal center B cells express the apoptosis-inducing genes Fas, c-myc, P53, and Bax but not the survival gene bcl-2. J Exp Med 183: 971-977.
38. Liu YJ, Arpin C, (1997) Germinal center development. Immunol Rev 156: 111-126.
39. MacLennan IC, (1994) Germinal centers. Annu Rev Immunol 12: 117-139.
40. Allen CD, Okada T, Tang HL, Cyster JG, (2007) Imaging of germinal center selection events during affinity maturation. Science 315: 528-531.
41. Victora GD, Schwickert TA, Fooksman DR, Kamphorst AO, Meyer-Hermann M, et al. (2010) Germinal center dynamics revealed by multiphoton microscopy with a photoactivatable fluorescent reporter. Cell 143: 592-605.
42. Epeldegui M, Hung YP, McQuay A, Ambinder RF, Martinez-Maza O, (2007) Infection of human B cells with Epstein-Barr virus results in the expression of somatic hypermutation-inducing molecules and in the accrual of oncogene mutations. Mol Immunol 44: 934-942.
43. Heath E, Begue-Pastor N, Chaganti S, Croom-Carter D, Shannon-Lowe C, et al. (2012) Epstein-Barr virus infection of naive B cells in vitro frequently selects clones with mutated immunoglobulin genotypes: implications for virus biology. PLoS Pathog 8: e1002697.
44. He B, Raab-Traub N, Casali P, Cerutti A, (2003) EBV-encoded latent membrane protein 1 cooperates with BAFF/BLyS and APRIL to induce T cell-independent Ig heavy chain class switching. J Immunol 171: 5215-5224.
45. Smith JD, Chitnis CE, Craig AG, Roberts DJ, Hudson-Taylor DE, et al. (1995) Switches in expression of Plasmodium falciparum var genes correlate with changes in antigenic and cytoadherent phenotypes of infected erythrocytes. Cell 82: 101-110.
46. Donati D, Zhang LP, Chene A, Chen Q, Flick K, et al. (2004) Identification of a polyclonal B-cell activator in Plasmodium falciparum. Infect Immun 72: 5412-5418.
47. Griffith JW, Sun T, McIntosh MT, Bucala R, (2009) Pure Hemozoin is inflammatory in vivo and activates the NALP3 inflammasome via release of uric acid. J Immunol 183: 5208-5220.
48. Jaramillo M, Bellemare MJ, Martel C, Shio MT, Contreras AP, et al. (2009) Synthetic Plasmodium-like hemozoin activates the immune response: a morphology- function study. PLoS One 4: e6957.
49. Roughan JE, Torgbor C, Thorley-Lawson DA, (2010) Germinal center B cells latently infected with Epstein-Barr virus proliferate extensively but do not increase in number. J Virol 84: 1158-1168.
50. Gross AJ, Hochberg D, Rand WM, Thorley-Lawson DA, (2005) EBV and systemic lupus erythematosus: a new perspective. J Immunol 174: 6599-6607.
51. Ho M, Webster HK, Looareesuwan S, Supanaranond W, Phillips RE, et al. (1986) Antigen-specific immunosuppression in human malaria due to Plasmodium falciparum. J Infect Dis 153: 763-771.
52. Hadinoto V, Shapiro M, Greenough TC, Sullivan JL, Luzuriaga K, et al. (2008) On the dynamics of acute EBV infection and the pathogenesis of infectious mononucleosis. Blood 111: 1420-1427.
53. Trager W, Jensen JB, (1976) Human malaria parasites in continuous culture. Science 193: 673-675.
54. Hornung V, Bauernfeind F, Halle A, Samstad EO, Kono H, et al. (2008) Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization. Nat Immunol 9: 847-856.